Generics

Filter

Current filters:

None

Popular Filters

110 to 134 of 1235 results

Zydus Cadila settles Asacol patent litigation in USA

11-12-2013

Zydus Cadila, one of India’s largest privately-held pharmaceuticals companies, and affiliate Zydus…

ActavisAsacol HDGastro-intestinalsGenericsNorth AmericaPatentsWarner ChilcottZydus Cadila

Australian government urged to hold the line on IP protection

Australian government urged to hold the line on IP protection

11-12-2013

The Generic Medicines Industry of Australia (GMiA) is renewing its call on the Australian government…

Asia-PacificAustraliaGenericsPatents

Teva vice chairman Moshe Many to leave post for 'personal reasons'

Teva vice chairman Moshe Many to leave post for 'personal reasons'

11-12-2013

Israel’s Teva Pharmaceutical Industries announced yesterday that the vice chairman of its board of…

BoardroomGenericsManagementTeva Pharmaceutical Industries

Russian government to change mechanism for setting prices for essential drugs

Russian government to change mechanism for setting prices for essential drugs

10-12-2013

The Russian government is considering changing the mechanism of setting prices for essential drugs in…

Eastern EuropeGenericsPharmaceuticalPricingRussia

Actavis sells 51% stake in Russian subsidiary

Actavis sells 51% stake in Russian subsidiary

10-12-2013

Leading global generics drugmaker Actavis says that it sold its 51% stake in the Russian drug company…

ActavisEastern EuropeFarmekoGenericsMergers & AcquisitionsRussiaZio-Zdorovye

Low level of “potentially problematic” patent settlements in EU pharma sector

Low level of “potentially problematic” patent settlements in EU pharma sector

09-12-2013

The European Commission's report on patent settlement agreements, also referred to as “pay-for-delay”…

EuropeFinancialGenericsPatentsPharmaceutical

AstraZeneca wins damages from Apotex

AstraZeneca wins damages from Apotex

04-12-2013

Anglo-Swedish drug major AstraZeneca this morning said it welcomed the US District Court for the Southern…

ApotexAstraZenecaFinancialGastro-intestinalsGenericsNexium I.V.North AmericaPatentsPrilosec

Sandoz in deal to market authorized generic of Shire’s Adderall XR in USA

Sandoz in deal to market authorized generic of Shire’s Adderall XR in USA

03-12-2013

UK drugmaker Shire says that its subsidiary Shire US Inc has entered into an agreement to supply an authorized…

Adderall XRGenericsLicensingNeurologicalNorth AmericaNovartisSandozShire

Mixed views on Grattan Institute report on drug price cuts impact in Australia

Mixed views on Grattan Institute report on drug price cuts impact in Australia

03-12-2013

The Grattan Institute has published an updated report on Australia's drug pricing, which has been applauded…

Asia-PacificAustraliaGenericsPoliticsPricing

Polpharma manufacturing division assimilates Sanfarm in Nowa Dęba

30-11-2013

Sanfarm, a company operating in the Tarnobrzeg Economic Zone in Poland, has become part of leading Polish…

Eastern EuropeGenericsMergers & AcquisitionsPolpharmaProductionSanfarm

Phased-in approach to implementing EU Falsified Medicines Directive recommended; report

29-11-2013

Addressing the fight against counterfeiting, in connection with the Falsified Medicines Directive, the…

EuropeGenericsMarkets & MarketingRegulation

KKR acquires $200 million stake in India’s Gland Pharma

KKR acquires $200 million stake in India’s Gland Pharma

29-11-2013

Indian injectable generic firm Gland Pharma says it has reached an agreement under which Kohlberg Kravis…

Asia-PacificGenericsGland PharmaMergers & Acquisitions

Brazil Court annuls marketing approval for sub-standard Taxotere biosimilar

Brazil Court annuls marketing approval for sub-standard Taxotere biosimilar

28-11-2013

The Superior Court of Justice in Brazil recently annulled marketing approval for a sub-standard biosimilar…

BiosimilarsDoxelibGenericsLegalLibra LaboratoryOncologyRegulationSanofiSouth AmericaTaxotere

No changes in Australian domestic IP warranted, say generic drugmakers

No changes in Australian domestic IP warranted, say generic drugmakers

26-11-2013

Members of the generic drugs industry are calling on the Australian government to support efforts to…

Asia-PacificGenericsNorth AmericaPatentsPolitics

Mylan-Biocon Herceptin biosimilar gets first Indian approval

Mylan-Biocon Herceptin biosimilar gets first Indian approval

26-11-2013

US generic major Mylan says that its partner, India-based biotechnology firm Biocon has received approval…

Asia-PacificBioconBiosimilarsGenericsHerceptinHertrazMylan LaboratoriesOncologyRegulationRoche

Actavis cuts 350 sales staff after acquisition of Warner Chilcott

Actavis cuts 350 sales staff after acquisition of Warner Chilcott

22-11-2013

US generics major Actavis (NYSE: ACT) says it has completed the restructuring of its US Specialty Brands…

ActavisFinancialGenericsManagementNorth AmericaUSAWarner Chilcott

A tendering system would threaten sustainability of Italian Pharma, argue trade groups

21-11-2013

After extensive assurances from the Italian government that stability would return to the Italian pharmaceutical…

EuropeFinancialGenericsHealthcare

Hikma in $40 million deal to enhance delivery of generic injectables

20-11-2013

USA-based Unilife Corp has signed a long-term commercial supply contract with Jordan-headquartered Hikma…

GenericsHikma PharmaceuticalsLicensingMarkets & MarketingUnilife Corp

DSM and JLL to create pharma services company in $2.6 billion transaction

20-11-2013

USA-based private equity firm JLL Partners and Dutch life and material science group Royal DSM have announced…

DSMGenericsMergers & Acquisitions

Teva updates on Lonquex and Granix launches

Teva updates on Lonquex and Granix launches

18-11-2013

Israel-based Teva Pharmaceutical Industries announced two significant additions to its global oncology…

balugrastimBiosimilarsEuropeGenericsLonquexMarkets & MarketingNorth AmericaOncologyRegulationTeva Pharmaceutical Industries

Mylan launches first generic Focalin XR capsules

Mylan launches first generic Focalin XR capsules

18-11-2013

US generics major Mylan has launched dexmethylphenidate hydrochloride extended-release (ER) capsules,…

Focalin XRGenericsMarkets & MarketingMylan LaboratoriesNeurologicalNorth AmericaNovartis

110 to 134 of 1235 results

Back to top